Tumor ID60 presented with a known hot-spot mutation in HRAS. Although no germline sequencing data were available, it can be assumed that this hot-spot mutation was somatic based on the gene involved and the low allele frequency of the variant. The gene discussed is HRAS; the disease is neoplasm.